WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), today announced that it expects to receive $1 million in grant funding to advance Tevogen.AI, its artificial intelligence–powered drug discovery and development program.
NEWARK, Del., Aug. 1, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce Project Call 9.1 for...
SERES fastest-rising company of Fortune China 2025, outpacing peers in China's competitive NEV market.
CHONGQING, China, Aug. 1, 2025 /PRNewswire/ -- SERES has emerged as this year's...
Jinhua, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (the “Company”, “we” or “Kandi Technologies”) (NASDAQ GS: KNDI), long renowned as a leader in all-electric personal transportation and utility vehicles, today announced its successful participation in the 2025 World Artificial Intelligence Conference (WAIC) in Shanghai, where it highlighted its AI-native technology innovations. During the event, Kandi Technologies’ strategic collaboration with Deep Robotics was featured as part of the broader conversation around intelligent mobility solutions.